Table 3. Summary of Clostridium difficile Event Rates per Hospital, Duke Infection Control Outreach Network, 2013a.
CDI Incidence Rate | LabID median, (IQR) | Traditional Surveillance median, (IQR) | Median Difference (IQR)a | P Value |
---|---|---|---|---|
HO rate per 10,000 patient-days | 5.70 (3.03–7.76) | 3.40 (1.71–4.75) | 1.24 (0.63–2.89) | <.001 |
CO-HCFA rate per 10,000 patient-days | 2.30 (1.25–3.89) | 2.53 (1.24–3.73) | 0 (−0.48–0) | .50 |
CA rate per 1,000 admissionsb | 4.01 (1.68–5.56) | 2.77 (1.50–5.51) | 0.51 (0–1.06) | <.001 |
Recurrent CDI rate per 1,000 admissionsb | 0.330 (0–1.13) | 0.478 (0.19–1.19) | −0.017 (−0.41–0) | <.001 |
LabID standardized infection ratioc | 0.78 (0.50–1.15) | N/A | N/A | N/A |
Note. CDI, Clostridium difficile infection; LabID, laboratory identified; IQR, interquartile range; HO, hospital-onset CDI; CO-HCFA, community-onset–healthcare-facility-associated CDI; CO, community-onset CDI; CA, community-associated CDI.
Median difference between LabID and traditional surveillance CDI incidence rates.
Observed LabID and traditional surveillance HO-CDI rates are different than overall data in this table due to missing LabID from one hospital, which was removed from the above analyses due to missing data.
SIR predicted NHSN LabID HO-CDI incidence rates were calculated from the Centers for Disease Control risk adjustment calculator.